Perceptive Advisors LLC G1 Therapeutics, Inc. Transaction History

Perceptive Advisors LLC

  • $3.83 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 14, 2020
SELL
$20.54 - $31.0 $322,519 - $486,762
-15,702 Closed
0 $0
Q3 2019

Nov 14, 2019
BUY
$22.78 - $40.58 $357,691 - $637,187
15,702 New
15,702 $358,000
Q4 2018

Feb 14, 2019
SELL
$16.51 - $51.33 $232,048 - $721,443
-14,055 Closed
0 $0
Q2 2018

Aug 14, 2018
BUY
$35.06 - $51.17 $492,768 - $719,194
14,055 New
14,055 $611,000

Others Institutions Holding GTHX

# of Institutions
6
Shares Held
3.55M
Call Options Held
11.7K
Put Options Held
0
View Full List

About G1 Therapeutics, Inc.

GTHX Quotes by TradingView
  • Ticker GTHX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,746,800
  • Market Cap $306M
  • Description
  • G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...
More about GTHX
Track This Portfolio

Track Perceptive Advisors LLC Portfolio

Follow Perceptive Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Perceptive Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email